India, Nov. 20 -- MEDIROM Healthcare Technologies Inc. (MRM) Wednesday said that it appealed a Nasdaq delisting determination and filed its overdue 2025 annual report on November 18.
The company received the notice on November 13, 2026, after failing to file its annual report on Form 20-F within an extension granted by Nasdaq, leaving it non-compliant with periodic reporting requirements.
The notice stated that its American Depositary Shares or ADSs would face suspension and delisting beginning November 24, unless the company appealed.
MEDIROM said it requested a hearing before a Nasdaq Hearings Panel. The request automatically postpones any trading suspension for 15 days. The company also requested an extended postponement pending compl...